Latest News and Press Releases
Want to stay updated on the latest news?
-
H.I.G. Capital, with $74B AUM, selects ToltIQ as its exclusive AI-powered due diligence platform following a two-month evaluation.
-
PRINCETON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and...
-
Bernard Ramirez Photo courtesy of Bryant Richardson Richardson, founder of Real Blue Sky, draws on decades of expertise to provide a clear guide for business leaders. The book explains his CRAFT...
-
ATLANTA, March 06, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Nutex Health, Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX) complied with federal securities...
-
PITTSBURGH, March 06, 2026 (GLOBE NEWSWIRE) -- Service Lighting, Inc. (“Service Lighting”), a Minnesota-based provider of light fixtures and bulbs,1 recently experienced a cybersecurity incident,...
-
Brookfield Real Assets Income Fund Inc. Announces Portfolio Management Team Change
-
CHARLOTTE, N.C., March 06, 2026 (GLOBE NEWSWIRE) -- Terrestrial Energy Inc. (NASDAQ: IMSR) (“Terrestrial Energy” or “the Company”), a developer of small modular nuclear power plants using its...
-
CAMBRIDGE, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of...
-
Strategic Action Aimed at Regaining Compliance with Nasdaq’s Minimum Bid Price Requirement and Protecting Continued Listing Status YOKNEAM ILLIT, ISRAEL, March 06, 2026 (GLOBE NEWSWIRE) -- ...
-
WALTHAM, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and...